QYX
- Product code
- QYX
- Device name
- Outpatient Cardiac Telemetry
- Device class
- Class 2
- 21 CFR
- 21 CFR 870.1025
- Medical specialty
- Cardiovascular
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 5
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 21 (all years; only the last 3 years are listed here)
FDA classification definition
Devices are intended to continuously record and analyze electrocardiograms for automatic detection and recording of cardiac electrical activity in an outpatient setting. Detected, notifiable events are transmitted to the prescribing clinician during the monitoring period by a 24/7 attended analysis center after review by a qualified individual. Devices may allow remote access and display of electrocardiograms acquired. Not for use for detection or notification of hemodynamically unstable or life-threatening arrhythmias or cardiac events requiring urgent medical response. Not intended for patients at elevated risk of serious cardiovascular events that would require prompt intervention. It is not intended for monitoring patients during cardiac rehabilitation outside of healthcare facilities. Devices are intended for prescription use only.
510(k) clearances, last 3 years (5)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K250793 | 2026-04-21 | RhythMedix, LLC | RhythmStar System (SL) | FDA |
| K241179 | 2025-07-11 | VivaQuant, Inc. | Rhythm Express Remote Cardiac Monitoring System (RX-… | |
| K240653 | 2024-10-31 | Smartcardia SA | SmartCardia 7L Platform (MCT) | FDA |
| K240029 | 2024-10-21 | iRhythm Technologies, Inc. | Zio AT® device (A100A1001) | |
| K233584 | 2024-07-08 | RhythMedix, LLC | RhythmStar System |